NORCROSS, Ga., June 27, 2023 /PRNewswire/ --
Koning Corporation, a global leader in breast computed tomography (CT) technology, is thrilled to announce the launch of its breakthrough Artificial Intelligence (AI) software, designed to enhance image quality significantly. The upgrade to their software system is set to provide unparalleled clarity in breast imaging, promising a game-changing impact on the early detection and treatment of breast cancer.
NORCROSS, Ga., June 6, 2023 /PRNewswire/ -- Koning Health announced today that its innovative breast imaging technology, the Koning Vera Breast CT, was named a finalist in the 2023 Sharecare Awards, which recognize best-in-class productions and programs that promote well-being and embody the spirit of "sharing care."
NORCROSS, Ga., May 15, 2023 /PRNewswire/ -- Koning Corporation, the leading manufacturer of breast computed tomography (CT) systems, announced today that it has received the largest pipeline of orders in its history. The company has seen a surge in demand for its innovative Koning Vera Breast CT system from healthcare providers around the world, as they seek to improve breast cancer detection and diagnosis.
WASHINGTON, April 20, 2023 /PRNewswire/ -- Koning Corporation, the leading developer and manufacturer of the innovative Koning Vera Breast CT, is proud to announce its participation in the upcoming Society of Breast Imaging Symposium to be held May 4-7 in Washington, DC. This event will bring together healthcare professionals and experts in breast imaging to discuss the latest advancements in breast cancer detection and treatment.
NORCROSS, Ga., Dec. 19, 2022 /PRNewswire/ -- Koning Corporation has announced the addition of Angélica Fuentes to their Board of Directors. Angélica Fuentes is a Mexican American businesswoman and investor recognized by Forbes Magazine as one of Mexico's most powerful women. Throughout her career, Ms. Fuentes has sustained a strong commitment to organizations supporting the cause of women.
Koning Corporation announces the addition of Latina businesswoman, Angélica Fuentes, to their Board of Directors.
NORCROSS, Ga., Dec. 12, 2022 /PRNewswire/ -- Koning is announcing the creation of a Scientific Advisory Board, adding several high-profile radiologists and researchers to its ranks. Among those who have joined the board are Dr. Richard Ha (Professor of Radiology at Columbia University in NY), Dr. Richard Reaven (Clinical Professor at University of Maryland), Dr. Kristina Siddall (Diagnostic Radiologist and Owner of Bayview Imaging in Miami, FL), and Dr. John A. Cutrone (Diagnostic Radiologist in Columbus, GA). All of these distinguished physicians are recognized as specialists in the field of breast imaging. Dr. Ioannis Sechopoulos (Professor of Radiology and Nuclear Medicine at Radboud University) has also joined the Scientific Advisory Board, and is an internationally recognized specialist in the science of breast CT.
NORCROSS, Ga., Sept. 27, 2022 /PRNewswire/ -- Last week, Koning Corporation was joined by top minds in the health, tech, and financial industries, for the inauguration of their new Koning Clinic. This event signifies the start of a new era for the company, as Koning begins to expand its operations across the country via retail clinics.
"It was amazing to meet all of the many investors, some of whom flew in internationally to support Koning," says Matthew Stack, Koning CFO. "To see such a global support network is inspiring and humbling to all of the Koning team."
Koning Corporation announces partnership with 11TEN Innovation Partners and DocPanel, beginning this month
NORCROSS, Ga., Sept. 8, 2022 /PRNewswire/ -- Koning has announced a new partnership with 11TEN Innovation Partners and DocPanel. This strategic alliance will be used to bring Koning's Breast Computerized Tomography (CT) to the masses through retail health channels. With the help of DocPanel, this new offering will allow for remote reading of scans and will assist in the growth and expansion of Breast CT as a comparable alternative to mammograms.
NORCROSS, Ga., Aug. 1, 2022 /PRNewswire/ -- Koning completed its prior funding campaigns on the Republic crowdfunding platform in January of this year, having raised over $2.1M. Building on that momentum, Koning was able to secure the highest number of device purchase orders in the company's history. To satisfy growing demand, Koning will raise additional capital.
NORCROSS, Ga., Feb. 1, 2022 /PRNewswire/ -- Koning, a growing medical device startup company based outside Atlanta, had a successful conclusion to 2021. The company recently finished their first Republic crowdfunding campaign, exceeding capital targets, and raising over $2.6M in only 5 months. Koning's FDA breast screening trial is also underway with participating clinics in Daytona Beach, FL and Knoxville, TN.
DAYTONA BEACH, Fla., Nov. 1, 2021 /PRNewswire/ -- Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device. The company received FDA PMA approval for commercial, diagnostic use in 2017. Since then, the Koning Breast CT (KBCT) has been installed in clinics and universities in the US and globally.
HONG KONG, Oct. 8, 2021 /PRNewswire/ -- Koning Corporation has been working to get more Koning Breast CT (KBCT) into clinics not only throughout the US, but also around the world. Within the past week, the company has entered into a partnership with Chesa Industries LTD with the intention of putting ten KBCT into clinics across Southeast Asia.
FOR IMMEDIATE RELEASE: SEPT 13, 2021
Atlanta, GA: A month into Koning’s Republic fundraising campaign, the company has already passed a quarter of a million dollars of investments from 740 investors.
“We’re proud of the progress we’ve made on the campaign so far and we’re confident that this positive trajectory will continue”, says Koning’s US CEO, Lutao Ning.
FOR IMMEDIATE RELEASE: AUG 27, 2021
Boston, MA: Koning has been selected as a finalist to present at the Women’s Health Innovation Summit on September 14, 2021. Of over 100 applicants, Koning is one of only ten companies that has been chosen and will showcase the Koning Breast CT - a technology that will change millions of women’s lives around the world through no compression, low dose, and true 3D imaging.
FOR IMMEDIATE RELEASE: AUG 11, 2021
Koning’s Series C fundraise is now available to both accredited and everyday investors via two leading tech investment websites.
Atlanta, GA: After launching on Revere on Monday, Koning Corporation has launched a second fundraising campaign on the investment platform Republic. “We’re very excited to be both on Republic and Revere. This is our official first public solicitation offering – a huge milestone for the company,” says Koning’s US CEO, Lutao Ning.
Atlanta, GA: Koning Corporation is now live on the investment platform, Revere, which specializes in raising funds for scalable, high-value technology companies.
On June 15th, 2020, the American Medical Association (AMA) granted 6 Category III CPT codes for the FDA PMA cleared dedicated breast CT imaging procedure. The newly assigned CPT codes in addition to the previous FDA PMA clearance process, formally introduces access to this new and advanced modality on January 1, 2021.